Science and innovation : the US pharmaceutical industry during the 1980s
Author(s)
Bibliographic Information
Science and innovation : the US pharmaceutical industry during the 1980s
Cambridge University Press, 1995
- : pbk
Available at 27 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references (p. 179-194) and index
Description and Table of Contents
Description
This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D.
Table of Contents
- List of figures
- List of tables
- Preface
- List of abbreviations
- 1. Introduction
- 2. Science and innovation in pharmaceutical research
- 3. Economic implications of greater scientific intensity in drug research
- 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies
- 5. Scientific research and drug discovery: an econometric investigation
- 6. A model of the innovation cycle in the pharmaceutical industry
- 7. Complementarity and external linkages: the strategies of large firms in biotechnology
- 8. Conclusions
- Notes
- References
- Index.
by "Nielsen BookData"